ArticleACS medicinal chemistry letters2016

Discovery of the Selective CYP17A1 Lyase Inhibitor BMS-351 for the Treatment of Prostate Cancer.

Audris Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.